Latest News
Environment in Association With Symptoms of Psychosis
Children With Autism Found to Have Higher Risk for Obesity
New Clinical Guideline on Injectable Opioid Agonist Treatment for Severe Opioid Use Disorder
Racial, Ethnic Minorities Want to See Doctor Who Shares Their Culture
Determinants of Real-World Functioning in Schizophrenia
Rapid Cycling Bipolar Disorder Associated With Hospitalization and Female Gender
Patient Portal Use Has Positive Impact on Preventive Health Behaviors
Openness to Experience Predicts Response to Ketamine Treatment
Depression Worse After Treatment in Few With MDD
Ketamine and Future Depression Treatments
Economic Hardship Results in Reduced Cognitive Function
Short-Term Cognitive Behavioral Therapy Effectively Reduced Adolescent Insomnia
Anxiety Sensitivity Associated With Migraine Severity in Women
Odds of Autism Up in Children With Congenital Heart Disease
Early Behavioral Inhibition Predicts Greater Anxiety in Adolescence With High Stress Levels
$8 Billion Award Granted in Risperdal Lawsuit
A Daytime Nap May Contribute to Altered Emotional Processing in Depression
Food for Thought: Mood Improvements Following Dietary Modification
Diet Intervention Can Cut Depression Symptoms in Young Adults
Latest Features
Schizophrenia, Bipolar Disorder, and the Psychosis Continuum
Awareness of differences between psychosis in schizophrenia and bipolar disorder and varying presentations in patients can assist providers with diagnosis and treatment.
Understanding CBD: How to Advise Patients About Existing Laws, Clinical Evidence, and More
At Psych Congress 2018, Andrew Penn from the UCSF School of Nursing provides insight into the use of CBD in clinical practice.
Drug-Free Chronotherapies Represent Unique Treatments for Depression
Researchers found that bright light therapy is a suitable option for those who must avoid antidepressant medications, such as individuals who are in perinatal and geriatric populations.
Insulin Resistance in Schizophrenia Occurs With and Without Antipsychotics
Researchers found data that showed patients with schizophrenia have an increased risk for metabolic disorders, and aripiprazole, lurasidone, and ziprasidone may offer the lowest risk for weight gain.
Is There a Link Between Drugs for Parkinson Disease and Gambling Disorders?
Pathological gambling was recently identified as a complication of Parkinson disease and its pharmacological treatment, especially high-dose dopaminergic agonists.
